Moderna, Inc. (MRNA) Revenue 2016–2025
Moderna, Inc. (MRNA) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.9BFY2025 · since FY2016: $108.4M → $1.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9B | -39.9% |
| FY2024 | $3.2B | -52.7% |
| FY2023 | $6.8B | -64.4% |
| FY2022 | $19.3B | +4.3% |
| FY2021 | $18.5B | +2200.2% |
| FY2020 | $803.0M | +1233.7% |
| FY2019 | $60.2M | -55.4% |
| FY2018 | $135.1M | -34.4% |
| FY2017 | $205.8M | +89.9% |
| FY2016 | $108.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRNA financial trends
MRNA Net incomeMRNA Net marginMRNA Gross profitMRNA Gross marginMRNA Operating incomeMRNA Operating marginMRNA Operating cash flowMRNA Free cash flowMRNA Capital expendituresMRNA Return on equityMRNA Stock buybacksMRNA Dividends paidMRNA Total assetsMRNA Total liabilitiesMRNA Shareholders’ equityMRNA overview →